Skip to main content
    S

    Sabra Healthcare REIT Inc (SBRA)

    Official site

    REAL ESTATE • REIT - HEALTHCARE FACILITIES • NASDAQ

    $20.35
    -0.09 (-0.44%)

    Market Cap: $5.35B

    Last updated: Nov 17, 2026 at 11:06 AM ET

    Sabra Healthcare REIT Inc (SBRA) P/E Ratio & Valuation History

    Updated Nov 17, 2026. Multiples are computed from end-of-day prices, company filings and consensus analyst estimates.

    Sabra Healthcare REIT (SBRA) trades at 12.2x its 2026 FFO estimate. Its forward P/E is 32.1x. It trades at 5.7x sales and 1.8x book value. Its P/S is below its 5-year median of 5.8x.

    Current Multiples

    Its P/FFO of 12.2x uses the 2026 FFO estimate of $1.67 per share. Its enterprise value is 27.2x its EBITDA. Its free cash flow yield is 6.6%.

    MultipleValue
    P/FFO (2026 estimate)12.2x
    P/E (trailing)18.8x
    Forward P/E32.1x
    Price to sales5.7x
    Price to book1.8x
    EV/EBITDA27.2x
    Price to FCF15.2x
    EV/FCF22.2x
    PEG5.3
    FCF yield6.6%
    As of Nov 17, 2026

    Historical Medians

    Against its 10-year medians, its P/E is 23.0% below 24.4x, its P/S is 1.7% below 5.8x and its P/B is 63.6% above 1.1x.

    MultipleCurrent5-year median10-year median
    P/E18.8x29.6x24.4x
    P/S5.7x5.8x5.8x
    P/B1.8x1.2x1.1x
    Medians of month-end values through Oct 2026: 48 to 60 months (5-year) and 108 to 120 months (10-year).

    Valuation History

    Over the 9 of the 10 year ends shown that have a P/E, its P/E ranged from 15.3x in 2017 to 52.1x in 2021.

    Year endPriceP/EP/SP/B
    2025$18.9420.8x5.9x1.7x
    2024$17.3228.4x5.8x1.5x
    2023$14.2736.6x5.1x1.2x
    2022$12.43N/A5.5x0.9x
    2021$13.5452.1x6.7x0.9x
    2020$17.3723.8x6.1x1.1x
    2019$21.3420.1x6.2x1.2x
    2018$16.4822.3x4.7x0.9x
    2017$18.7715.3x5.4x1.0x
    2016$24.4227.1x6.0x1.6x
    Each year's multiples use the split-adjusted closing price of that year's last trading day over trailing per-share results as reported; periods with losses are left out.

    GNG Valuation

    GNG viewFairly valued

    GNG fair value is part of GNG Pro. See plans

    Frequently Asked Questions About SBRA

    What is SBRA's forward P/E ratio?

    Sabra Healthcare REIT has a forward P/E ratio of 32.1x. It trades at 12.2x its 2026 FFO estimate.

    Is SBRA stock overvalued?

    Sabra Healthcare REIT trades at 12.2x its 2026 FFO estimate. GNG's valuation label for SBRA is Fairly valued.

    What is SBRA's price to sales ratio?

    Sabra Healthcare REIT has a price to sales ratio of 5.7x.

    What is Sabra Healthcare REIT's average P/E ratio over 5 years?

    Sabra Healthcare REIT's median P/E over the last 5 years is 29.6x, from 48 month-end values through Oct 2026. It trades at 12.2x its 2026 FFO estimate.

    What is SBRA's PEG ratio?

    Sabra Healthcare REIT has a PEG ratio of 5.3.